The global Mycosis Fungoides Therapeutics market is projected to grow from US$ 565.1 million in 2024 to US$ 730.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

Mycosis Fungoides Therapeutics Market

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and there is an increase in its incidence of mycosis fungoides.

Market Analysis and Insights: Global Mycosis Fungoides Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Mycosis Fungoides Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Mycosis Fungoides Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Mycosis Fungoides Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mycosis Fungoides Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mycosis Fungoides Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mycosis Fungoides Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Mycosis Fungoides Therapeutics Market Report

Report Metric	Details
Report Name	Mycosis Fungoides Therapeutics Market
Accounted market size in 2024	US$ 565.1 million
Forecasted market size in 2030	US$ 730.8 million
CAGR	4.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Small Molecules Biologics
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Azurity Pharmaceuticals Inc., Celgene Corp., Eisai Co. Ltd., Helsinn Healthcare SA, Horizon Therapeutics Plc, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Seattle Genetics Inc., Soligenix Inc., Takeda Pharmaceutical Co. Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Mycosis Fungoides Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycosis Fungoides Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycosis Fungoides Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Mycosis Fungoides Therapeutics Market growing?

Ans: The Mycosis Fungoides Therapeutics Market witnessing a CAGR of 4.4 during the forecast period 2025-2030.

What is the Mycosis Fungoides Therapeutics Market size in 2030?

Ans: The Mycosis Fungoides Therapeutics Market size in 2030 will be US$ 730.8 million.

Who are the main players in the Mycosis Fungoides Therapeutics Market report?

Ans: The main players in the Mycosis Fungoides Therapeutics Market are Azurity Pharmaceuticals Inc., Celgene Corp., Eisai Co. Ltd., Helsinn Healthcare SA, Horizon Therapeutics Plc, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Seattle Genetics Inc., Soligenix Inc., Takeda Pharmaceutical Co. Ltd.

What are the Application segmentation covered in the Mycosis Fungoides Therapeutics Market report?

Ans: The Applications covered in the Mycosis Fungoides Therapeutics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Mycosis Fungoides Therapeutics Market report?

Ans: The Types covered in the Mycosis Fungoides Therapeutics Market report are Small Molecules, Biologics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Small Molecules

1.2.3 Biologics

1.3 Market by Application

1.3.1 Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mycosis Fungoides Therapeutics Market Perspective (2019-2030)

2.2 Global Mycosis Fungoides Therapeutics Growth Trends by Region

2.2.1 Mycosis Fungoides Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Mycosis Fungoides Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Mycosis Fungoides Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Mycosis Fungoides Therapeutics Market Dynamics

2.3.1 Mycosis Fungoides Therapeutics Industry Trends

2.3.2 Mycosis Fungoides Therapeutics Market Drivers

2.3.3 Mycosis Fungoides Therapeutics Market Challenges

2.3.4 Mycosis Fungoides Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Mycosis Fungoides Therapeutics by Players

3.1.1 Global Mycosis Fungoides Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Mycosis Fungoides Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Mycosis Fungoides Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Mycosis Fungoides Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Mycosis Fungoides Therapeutics Market Concentration Ratio

3.4.1 Global Mycosis Fungoides Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Therapeutics Revenue in 2023

3.5 Global Key Players of Mycosis Fungoides Therapeutics Head office and Area Served

3.6 Global Key Players of Mycosis Fungoides Therapeutics, Product and Application

3.7 Global Key Players of Mycosis Fungoides Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Mycosis Fungoides Therapeutics Breakdown Data by Type

4.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2025-2030)

5 Mycosis Fungoides Therapeutics Breakdown Data by Application

5.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Mycosis Fungoides Therapeutics Market Size (2019-2030)

6.2 North America Mycosis Fungoides Therapeutics Market Size by Type

6.2.1 North America Mycosis Fungoides Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Mycosis Fungoides Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

6.3 North America Mycosis Fungoides Therapeutics Market Size by Application

6.3.1 North America Mycosis Fungoides Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Mycosis Fungoides Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

6.4 North America Mycosis Fungoides Therapeutics Market Size by Country

6.4.1 North America Mycosis Fungoides Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Mycosis Fungoides Therapeutics Market Size (2019-2030)

7.2 Europe Mycosis Fungoides Therapeutics Market Size by Type

7.2.1 Europe Mycosis Fungoides Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Mycosis Fungoides Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

7.3 Europe Mycosis Fungoides Therapeutics Market Size by Application

7.3.1 Europe Mycosis Fungoides Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Mycosis Fungoides Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

7.4 Europe Mycosis Fungoides Therapeutics Market Size by Country

7.4.1 Europe Mycosis Fungoides Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Mycosis Fungoides Therapeutics Market Size (2019-2030)

8.2 China Mycosis Fungoides Therapeutics Market Size by Type

8.2.1 China Mycosis Fungoides Therapeutics Market Size by Type (2019-2024)

8.2.2 China Mycosis Fungoides Therapeutics Market Size by Type (2025-2030)

8.2.3 China Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

8.3 China Mycosis Fungoides Therapeutics Market Size by Application

8.3.1 China Mycosis Fungoides Therapeutics Market Size by Application (2019-2024)

8.3.2 China Mycosis Fungoides Therapeutics Market Size by Application (2025-2030)

8.3.3 China Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Mycosis Fungoides Therapeutics Market Size (2019-2030)

9.2 Asia Mycosis Fungoides Therapeutics Market Size by Type

9.2.1 Asia Mycosis Fungoides Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Mycosis Fungoides Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

9.3 Asia Mycosis Fungoides Therapeutics Market Size by Application

9.3.1 Asia Mycosis Fungoides Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Mycosis Fungoides Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

9.4 Asia Mycosis Fungoides Therapeutics Market Size by Region

9.4.1 Asia Mycosis Fungoides Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Mycosis Fungoides Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Mycosis Fungoides Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Azurity Pharmaceuticals Inc.

11.1.1 Azurity Pharmaceuticals Inc. Company Details

11.1.2 Azurity Pharmaceuticals Inc. Business Overview

11.1.3 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Introduction

11.1.4 Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.1.5 Azurity Pharmaceuticals Inc. Recent Developments

11.2 Celgene Corp.

11.2.1 Celgene Corp. Company Details

11.2.2 Celgene Corp. Business Overview

11.2.3 Celgene Corp. Mycosis Fungoides Therapeutics Introduction

11.2.4 Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.2.5 Celgene Corp. Recent Developments

11.3 Eisai Co. Ltd.

11.3.1 Eisai Co. Ltd. Company Details

11.3.2 Eisai Co. Ltd. Business Overview

11.3.3 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.3.4 Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.3.5 Eisai Co. Ltd. Recent Developments

11.4 Helsinn Healthcare SA

11.4.1 Helsinn Healthcare SA Company Details

11.4.2 Helsinn Healthcare SA Business Overview

11.4.3 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Introduction

11.4.4 Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.4.5 Helsinn Healthcare SA Recent Developments

11.5 Horizon Therapeutics Plc

11.5.1 Horizon Therapeutics Plc Company Details

11.5.2 Horizon Therapeutics Plc Business Overview

11.5.3 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Introduction

11.5.4 Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.5.5 Horizon Therapeutics Plc Recent Developments

11.6 Kyowa Kirin Co. Ltd.

11.6.1 Kyowa Kirin Co. Ltd. Company Details

11.6.2 Kyowa Kirin Co. Ltd. Business Overview

11.6.3 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.6.4 Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.6.5 Kyowa Kirin Co. Ltd. Recent Developments

11.7 Merck & Co. Inc.

11.7.1 Merck & Co. Inc. Company Details

11.7.2 Merck & Co. Inc. Business Overview

11.7.3 Merck & Co. Inc. Mycosis Fungoides Therapeutics Introduction

11.7.4 Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.7.5 Merck & Co. Inc. Recent Developments

11.8 Seattle Genetics Inc.

11.8.1 Seattle Genetics Inc. Company Details

11.8.2 Seattle Genetics Inc. Business Overview

11.8.3 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Introduction

11.8.4 Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.8.5 Seattle Genetics Inc. Recent Developments

11.9 Soligenix Inc.

11.9.1 Soligenix Inc. Company Details

11.9.2 Soligenix Inc. Business Overview

11.9.3 Soligenix Inc. Mycosis Fungoides Therapeutics Introduction

11.9.4 Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.9.5 Soligenix Inc. Recent Developments

11.10 Takeda Pharmaceutical Co. Ltd.

11.10.1 Takeda Pharmaceutical Co. Ltd. Company Details

11.10.2 Takeda Pharmaceutical Co. Ltd. Business Overview

11.10.3 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.10.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.10.5 Takeda Pharmaceutical Co. Ltd. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Azurity Pharmaceuticals Inc.

Celgene Corp

Eisai Co Ltd

Helsinn Healthcare SA

Horizon Therapeutics plc

Kyowa Kirin Co., Ltd.

Merck& Co. Inc

Seattle Genetics Inc

Soligenix Inc

Takeda Pharmaceutical Co Ltd

List of Tables

Table 1. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Small Molecules

Table 3. Key Players of Biologics

Table 4. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Mycosis Fungoides Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Mycosis Fungoides Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Mycosis Fungoides Therapeutics Market Share by Region (2019-2024)

Table 8. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Mycosis Fungoides Therapeutics Market Share by Region (2025-2030)

Table 10. Mycosis Fungoides Therapeutics Market Trends

Table 11. Mycosis Fungoides Therapeutics Market Drivers

Table 12. Mycosis Fungoides Therapeutics Market Challenges

Table 13. Mycosis Fungoides Therapeutics Market Restraints

Table 14. Global Mycosis Fungoides Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Mycosis Fungoides Therapeutics Revenue Share by Players (2019-2024)

Table 16. Global Top Mycosis Fungoides Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Therapeutics as of 2023)

Table 17. Global Mycosis Fungoides Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Mycosis Fungoides Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Mycosis Fungoides Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Mycosis Fungoides Therapeutics, Product and Application

Table 21. Global Key Players of Mycosis Fungoides Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Mycosis Fungoides Therapeutics Revenue Share by Application (2019-2024)

Table 29. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Mycosis Fungoides Therapeutics Revenue Share by Application (2025-2030)

Table 31. North America Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Mycosis Fungoides Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Mycosis Fungoides Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Mycosis Fungoides Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Mycosis Fungoides Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Mycosis Fungoides Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Mycosis Fungoides Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Mycosis Fungoides Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Mycosis Fungoides Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Mycosis Fungoides Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Mycosis Fungoides Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Mycosis Fungoides Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Mycosis Fungoides Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Mycosis Fungoides Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 63. Azurity Pharmaceuticals Inc. Company Details

Table 64. Azurity Pharmaceuticals Inc. Business Overview

Table 65. Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Product

Table 66. Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Azurity Pharmaceuticals Inc. Recent Developments

Table 68. Celgene Corp. Company Details

Table 69. Celgene Corp. Business Overview

Table 70. Celgene Corp. Mycosis Fungoides Therapeutics Product

Table 71. Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Celgene Corp. Recent Developments

Table 73. Eisai Co. Ltd. Company Details

Table 74. Eisai Co. Ltd. Business Overview

Table 75. Eisai Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 76. Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Eisai Co. Ltd. Recent Developments

Table 78. Helsinn Healthcare SA Company Details

Table 79. Helsinn Healthcare SA Business Overview

Table 80. Helsinn Healthcare SA Mycosis Fungoides Therapeutics Product

Table 81. Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Helsinn Healthcare SA Recent Developments

Table 83. Horizon Therapeutics Plc Company Details

Table 84. Horizon Therapeutics Plc Business Overview

Table 85. Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Product

Table 86. Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Horizon Therapeutics Plc Recent Developments

Table 88. Kyowa Kirin Co. Ltd. Company Details

Table 89. Kyowa Kirin Co. Ltd. Business Overview

Table 90. Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 91. Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Kyowa Kirin Co. Ltd. Recent Developments

Table 93. Merck & Co. Inc. Company Details

Table 94. Merck & Co. Inc. Business Overview

Table 95. Merck & Co. Inc. Mycosis Fungoides Therapeutics Product

Table 96. Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Merck & Co. Inc. Recent Developments

Table 98. Seattle Genetics Inc. Company Details

Table 99. Seattle Genetics Inc. Business Overview

Table 100. Seattle Genetics Inc. Mycosis Fungoides Therapeutics Product

Table 101. Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Seattle Genetics Inc. Recent Developments

Table 103. Soligenix Inc. Company Details

Table 104. Soligenix Inc. Business Overview

Table 105. Soligenix Inc. Mycosis Fungoides Therapeutics Product

Table 106. Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 107. Soligenix Inc. Recent Developments

Table 108. Takeda Pharmaceutical Co. Ltd. Company Details

Table 109. Takeda Pharmaceutical Co. Ltd. Business Overview

Table 110. Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 111. Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Takeda Pharmaceutical Co. Ltd. Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Mycosis Fungoides Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Small Molecules Features

Figure 4. Biologics Features

Figure 5. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Mycosis Fungoides Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Mycosis Fungoides Therapeutics Report Years Considered

Figure 11. Global Mycosis Fungoides Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Mycosis Fungoides Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Mycosis Fungoides Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Mycosis Fungoides Therapeutics Market Share by Players in 2023

Figure 15. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Mycosis Fungoides Therapeutics Revenue in 2023

Figure 17. North America Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

Figure 19. North America Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

Figure 20. North America Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Mycosis Fungoides Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Mycosis Fungoides Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

Figure 35. China Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia Mycosis Fungoides Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Mycosis Fungoides Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Azurity Pharmaceuticals Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 57. Celgene Corp. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 58. Eisai Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 59. Helsinn Healthcare SA Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 60. Horizon Therapeutics Plc Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 61. Kyowa Kirin Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 62. Merck & Co. Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 63. Seattle Genetics Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 64. Soligenix Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 65. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions